Creating and distributing additional copies is prohibited without the permission of the publisher. Contact subscriptions@latinfinance.com.

Brazil Pharma Plans Follow-on

May 9, 2012

Brazil Pharma plans to raise BRL600m ($316m) in an equity follow-on, it...

To continue reading please take a free trial, subscribe or login below.


Already have an account?

Subscribe

Subscribe now for unlimited access to all current and archive news, data and market analysis. 

Subscribe

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial

LatinFinance Events

Poll

Is recent bond market volatility the end of easy borrowing for LatAm issuers?

Vote    



  1. Institutional wealth – pension funds: The next generation
  2. No Fear on Long-Term Investment: AmBev
  3. Debt investor scorecard: Beating the benchmark
  4. Brazilian investor scorecard: Sitting tight
  5. Man of the year: Seize the moment


Popular Searches


At a fundamental level, the issue is how to generate healthy returns in the medium to long term. Policy holders can see their fund go down over the course of a week or a month, but what we really should be looking at is returns over 20 or 30 years.

Daniel Schydlowsky, Peru’s banking, insurance and private pension fund regulator


Change font size: Switch to default font size Switch to medium font size Switch to large font size

All material is subject to strictly enforced copyright terms & conditions and cannot be repurposed or reproduced. © 2013 Latin American Financial Publications Inc.

Printing isn't available for this page.